Skip to main content
Genmab A/S (CPH: GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,447.50
+2.50 (0.17%)
Nov 21, 2024, 4:59 PM CET

Genmab Revenue

Genmab had revenue of 5.54B DKK in the quarter ending September 30, 2024, with 17.57% growth. This brings the company's revenue in the last twelve months to 19.84B, up 17.75% year-over-year. In the year 2023, Genmab had annual revenue of 16.47B with 13.57% growth.

Revenue (ttm)
19.84B
Revenue Growth
+17.75%
P/S Ratio
4.72
Revenue / Employee
7.53M
Employees
2,204
Market Cap
91.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202316.47B1.97B13.57%
Dec 31, 202214.51B6.09B72.33%
Dec 31, 20218.42B-1.69B-16.75%
Dec 31, 202010.11B4.75B88.43%
Dec 31, 20195.37B2.34B77.39%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk A/S 270.58B
Coloplast A/S 27.03B
Demant A/S 22.84B
Zealand Pharma A/S 76.87M
H. Lundbeck A/S 21.44B
H. Lundbeck A/S 21.44B
ALK-Abelló A/S 5.38B
Ambu A/S 5.39B
Revenue Rankings

Genmab News

More News